Early side effects and first results of radioligand therapy with 177Lu-DKFZ-617 PSMA of castrate-resistant metastatic prostate cancer: a two-centre study
Crossref DOI link: https://doi.org/10.1186/s13550-015-0114-2
Published Online: 2015-06-20
Published Print: 2015-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Ahmadzadehfar, Hojjat
Rahbar, Kambiz
Kürpig, Stefan
Bögemann, Martin
Claesener, Michael
Eppard, Elisabeth
Gärtner, Florian
Rogenhofer, Sebastian
Schäfers, Michael
Essler, Markus
License valid from 2015-06-20